Your browser doesn't support javascript.
loading
Telmisartan inhibits Ang II-induced MMP-9 expression in macrophages in stabilizing atheromatous plaque.
Shen, Z-J; Xu, C-S; Li, Y-P; Li, J; Xu, J-J; Xia, P.
Afiliación
  • Shen ZJ; Department of Cardiovascular Medicine, Huanggang Central Hospital, Huanggang, China. 13581267923@163.com.
Eur Rev Med Pharmacol Sci ; 22(22): 8004-8012, 2018 11.
Article en En | MEDLINE | ID: mdl-30536349
OBJECTIVE: To investigate the effects of telmisartan on matrix metalloproteinase-9 (MMP-9) expression in macrophages induced by angiotensin II (Ang II) and its mechanism. MATERIALS AND METHODS: THP-1 cells were adopted for research, and phorbol-12-myristate-13-acetate (PMA) was utilized to induce THP-1 cells to be transformed into macrophages, with Ang II as a stimulating factor and telmisartan as a therapeutic drug. Cell counting kit-8 (CCK8) and lactate dehydrogenase (LDH) were applied to detect cell viability and toxicity. Enzyme-linked immunosorbent assay (ELISA) was performed to measure the MMP-9 release level. Polymerase Chain Reaction (PCR) and Western blotting were conducted to detect the expressions of MMP-9 messenger ribonucleic acid (mRNA) and protein, respectively. The mechanism of action was further studied, and the activity of cyclooxygenase-2 (COX2)/macrophage-expressed gene 1 (mPEG1) pathway was determined via PCR and Western blotting. RESULTS: The 1 mM Ang II could remarkably activate the synthesis and release of MMP-9 as well as the COX2/mPEG1 pathway in macrophages. However, telmisartan could effectively repress the Ang II-induced MMP-9 synthesis and release in the macrophages, and suppress the COX2/mPEG1 pathway in the macrophages activated by Ang II. CONCLUSIONS: Telmisartan can inhibit the activation of MMP-9 in the macrophages by suppressing the COX2/mPEG1 pathway.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Angiotensina II / Metaloproteinasa 9 de la Matriz / Bloqueadores del Receptor Tipo 1 de Angiotensina II / Placa Aterosclerótica / Telmisartán / Macrófagos Límite: Humans Idioma: En Revista: Eur Rev Med Pharmacol Sci Asunto de la revista: FARMACOLOGIA / TOXICOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: China Pais de publicación: Italia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Angiotensina II / Metaloproteinasa 9 de la Matriz / Bloqueadores del Receptor Tipo 1 de Angiotensina II / Placa Aterosclerótica / Telmisartán / Macrófagos Límite: Humans Idioma: En Revista: Eur Rev Med Pharmacol Sci Asunto de la revista: FARMACOLOGIA / TOXICOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: China Pais de publicación: Italia